Dicerna Pharmaceuticals
DRNA
#4208
Rank
C$4.17 B
Marketcap
C$53.57
Share price
0.00%
Change (1 day)
17,565.11%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: C$4.17 Billion

As of August 2026 Dicerna Pharmaceuticals has a market cap of C$4.17 Billion. This makes Dicerna Pharmaceuticals the world's 4208th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022C$4.04 B6.47%
2021C$3.79 B78.33%
2020C$2.12 B3.33%
2019C$2.05 B107.33%
2018C$0.99 B69.42%
2017C$0.58 B629.94%
2016C$80.32 M-76.31%
2015C$0.33 B-0.25%
2014C$0.33 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$199.80 B 4,687.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$291.37 B 6,881.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$450.74 B 10,699.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$0.79 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$38.46 B 821.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$16.71 B 300.43%๐Ÿ‡บ๐Ÿ‡ธ USA